Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Red cell transfusions and guidelines: a work in progress.

Bruce D Spiess1

  • 1Department of Anesthesiology, Virginia Commonwealth University Medical Center, 1200 East Broad Street, Richmond, VA 23298-0695, USA. bdspiess@hsc.vcu

Hematology/Oncology Clinics of North America
|January 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Cohort, Semi-Randomized, open label quality improvement patient blood management (PBM) comparison of point of care viscoelastic coagulation monitors in cardiac surgery.

Journal of clinical monitoring and computing·2026
Same author

Vasoplegia and cardiopulmonary bypass: role of oxidation-reduction dysregulation as a mechanism and therapeutic target.

British journal of anaesthesia·2025
Same author

Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced immunosuppression.

JCI insight·2025
Same author

An Ironclad Case for Patient Blood Management: Iron Is More Than Hemoglobin.

Anesthesia and analgesia·2024
Same author

Association Between Preoperative Anemia and Cognitive Function in a Large Cohort Study of Older Patients Undergoing Elective Surgery.

Anesthesia and analgesia·2024
Same author

Silk Fibroin Particles as Carriers in the Development of Hemoglobin-Based Oxygen Carriers.

Advanced nanobiomed research·2024
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Blood transfusions are increasing but lack safety testing. Emerging evidence suggests potential risks associated with allogeneic transfusions, questioning current red blood cell transfusion practices.

Area of Science:

  • Transfusion Medicine
  • Hematology
  • Critical Care Medicine

Background:

  • Blood transfusion utilization is rising globally.
  • There is a lack of prospective safety and efficacy data for transfusions.
  • Concerns exist regarding the physiological impact of transfusions.

Purpose of the Study:

  • To evaluate the current practices of red blood cell transfusion.
  • To examine the potential risks associated with allogeneic transfusions.
  • To question the established protocols for blood product administration.

Main Methods:

  • Review of recent data on oxygen delivery.
  • Analysis of microcirculation changes post-transfusion.
  • Assessment of inflammatory markers after transfusion.

Related Experiment Videos

  • Examination of retrospective outcome databases.

    • Main Results:

    • Data suggest potential issues with oxygen delivery.
    • Microcirculation may be adversely affected by transfusions.
    • Inflammatory responses are a concern.
    • Retrospective data raise questions about transfusion efficacy.

    Conclusions:

    • Current red blood cell transfusion practices warrant critical re-evaluation.
    • Allogeneic transfusions may pose risks not fully understood.
    • Further prospective research is needed to establish optimal transfusion guidelines.